A carregar...
An update on the use of transdermal oxybutynin in the management of overactive bladder disorder
Antimuscarinic medications are used to treat nonneurogenic overactive bladder refractory to nonpharmacologic therapy. Side effects such as dry mouth, constipation, blurred vision, dizziness, and impaired cognition limit the tolerability of therapy and are largely responsible for high discontinuation...
Na minha lista:
| Publicado no: | Ther Adv Urol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772360/ https://ncbi.nlm.nih.gov/pubmed/27034721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215626312 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|